Detection of pattern of myocardial fibrosis by contrast-enhanced MRI: Is redefinition of uremic cardiomyopathy necessary for management of patients?

被引：6

作者：

Aoki, J. ^{[1
]}

Hara, K. ^{[1
]}

机构：

[1] Mitsui Mem Hosp, Div Cardiol, Chiyoda Ku, Tokyo 1110043, Japan

来源：

KIDNEY INTERNATIONAL | 2006年 / 69卷 / 10期

关键词：

D O I：

10.1038/sj.ki.5000259

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Cardiac magnetic resonance imaging ( CMR) can detect cardiac tissue components for several kinds of cardiac myopathies. Mark et al. found two patterns of late gadolinium enhancement ( LGE) in patients with uremic cardiomyopathy: focal LGE and diffuse LGE. The impact of these contrast-enhanced CMR findings on clinical outcomes warrants assessment in future studies.

引用

页码：1711 / 1712

页数：3

共 10 条

[1] Clinical and pathologic characteristics of dilated cardiomyopathy in hemodialysis patients [J].

Aoki, J ;

Ikari, Y ;

Nakajima, H ;

Mori, M ;

Sugimoto, T ;

Hatori, M ;

Tanimoto, S ;

Amiya, E ;

Hara, K .

KIDNEY INTERNATIONAL, 2005, 67 (01) :333-340

[2] Impact of moderate renal insufficiency on restenosis and adverse clinical events after paclitaxel-eluting and bare metal stent implantation: Results from the TAXUS-IV Trial [J].

Halkin, A ;

Mehran, R ;

Casey, CW ;

Gordon, P ;

Matthews, R ;

Wilson, BH ;

Leon, MB ;

Russell, ME ;

Ellis, SG ;

Stone, GW .

AMERICAN HEART JOURNAL, 2005, 150 (06) :1163-1170

[3] Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes [J].

Herzog, CA ;

Ma, JZ .

CIRCULATION, 2002, 106 (17) :2207-2211

[4] The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. [J].

Kim, RJ ;

Wu, E ;

Rafael, A ;

Chen, EL ;

Parker, MA ;

Simonetti, O ;

Klocke, FJ ;

Bonow, RO ;

Judd, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (20) :1445-1453

[5]

Maceira AM, 2005, CIRCULATION, V111, P186, DOI 10.1161/01.CIR.0000152819.97857.9D

[6] Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging [J].

Mark, P. B. ;

Johnston, N. ;

Groenning, B. A. ;

Foster, J. E. ;

Blyth, K. G. ;

Martin, T. N. ;

Steedman, T. ;

Dargie, H. J. ;

Jardine, A. G. .

KIDNEY INTERNATIONAL, 2006, 69 (10) :1839-1845

[7] High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography [J].

Mollet, NR ;

Cademartiri, F ;

van Mieghem, CAG ;

Runza, G ;

McFadden, EP ;

Baks, T ;

Serruys, PW ;

Krestin, GP ;

de Feyter, PJ .

CIRCULATION, 2005, 112 (15) :2318-2323

[8] The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy [J].

Moon, JCC ;

Reed, E ;

Sheppard, MN ;

Elkington, AG ;

Ho, SY ;

Burke, M ;

Petrou, M ;

Pennell, DJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2260-2264

[9] Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis [J].

Smedema, JP ;

Snoep, G ;

van Kroonenburgh, MPG ;

van Geuns, RJ ;

Dassen, WRM ;

Gorgels, APM ;

Crijns, HJGM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (10) :1683-1690

[10] Morphology of the heart and arteries in renal failure [J].

Tyralla, K ;

Amann, K .

KIDNEY INTERNATIONAL, 2003, 63 :S80-S83

← 1 →